ADMA Biologics (ADMA) Reports Q2 Loss of $0.35/Share

ADMA Biologics (NASDAQ: ADMA) reported Q2 EPS of ($0.35), versus ($0.55) reported last year. Revenue for the quarter came in at $4.7 million, versus $3.4 million reported last year.

For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
• HSBC Upgrades Blue Star Limited (BLSTR:IN) to Buy